The cost of tissue plasminogen activator (tPA), or alteplase, a clot-busting drug used to treat stroke patients, has doubled in the past decade, while reimbursement to hospitals for the use of tPA has ...

Apr. 14—URBANA — For decades, hospitals have treated strokes caused by blood clots with the standard clot-busting drug alteplase. Now, OSF HealthCare hospitals have joined several others that have ...

Ten years ago, a crucial study proved that a drug could limit the damage from one of nature's biggest train wrecks: a blood clot stuck inside the head. The drug, TPA, was so powerful at dissolving ...

Since 2022, the hospital has not been providing the life-saving, clot-dissolving TPA drug and instead sending stroke patients ...

An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. Photo by Adobe Stock/HealthDay News An off-label ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

BOSTON (Reuters) - Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released on Wednesday shows the drug still does some good as ...

HUDSON — Columbia Memorial Hospital has a new way to fight strokes. The hospital is using a new clot-busting drug known as Tissue Plasminogen Activator, or TPA. The New York state Department of Health ...

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later ...

Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...

BOSTON, Sept 24 (Reuters) - Doctors are given just three hours to administer the clot-busting drug alteplase to help stroke patients, but a study released on Wednesday shows the drug still does some ...